Epigenetic reprogramming is emerging as one of the most intriguing ideas in aging research—the possibility that aging is not just damage, but also a reversible loss of cellular identity. In this episode, we explore how scientists are trying to reset the epigenetic instructions that control gene expression, tissue function, and biological age. We break down the science behind partial reprogramming, what preclinical studies suggest about rejuvenation, regeneration, and lifespan-related outcomes, and why safety, durability, and cancer risk remain major challenges. Can aging really be reversed, or are we only beginning to understand the code that drives it?
Podden och tillhörande omslagsbild på den här sidan tillhör
Vinod Reddy Lekkala. Innehållet i podden är skapat av Vinod Reddy Lekkala och inte av,
eller tillsammans med, Poddtoppen.
